Lv3
232 积分 2026-01-16 加入
The emerging landscape of lncRNAs in gastric cancer immunity: From immune escape to ferroptosis and metabolic reprogramming
3天前
已关闭
Exploration of the benefits and resistance mechanisms of immunotherapy based on PD-L1 expression, circulating tumor DNA and T-cell receptor profiles in advanced gastric cancer
17天前
已关闭
Liquid biopsy for the management of gastrointestinal cancers
17天前
已完结
Immunosuppressive immune microenvironment landscapes in VISTA-high gastric cancer
17天前
已完结
The tumor microenvironment shapes gastric cancer progression by coordinating immune suppression and metabolic reprogramming
18天前
已完结
Spatial profiling of patient-matched HER2 positive gastric cancer reveals resistance mechanisms to targeted therapy
18天前
已完结
Beyond tumor mutational burden: a framework for immune-checkpoint blockade responsiveness in gastrointestinal cancers
18天前
已完结
Ubenimex synergizes with the PD-L1 blockade in gastric cancer by competitively binding LAP3 with UBE3A
18天前
已关闭
Ubenimex synergizes with the PD-L1 blockade in gastric cancer by competitively binding LAP3 with UBE3A
18天前
已关闭
Integrated molecular and microenvironmental drivers of drug resistance in gastrointestinal cancers: mechanisms, immunotherapy challenges, and precision strategies
18天前
已完结
皖公网安备34019202002308
